Inventor
BROWN DENNIS M
GB41 patents
⚠️ This page may combine multiple inventors who share the name “BROWN DENNIS M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BROWN DENNIS M
8 patentsUS9066918B2Jun 30, 2015
Methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
BROWN DENNIS M6 citations72
US12336993B2Jun 24, 2025
Therapeutic benefit of suboptimally administered chemical compounds
BROWN DENNIS M0 citations62
US11491154B2Nov 8, 2022
Therapeutic benefit of suboptimally administered chemical compounds
BROWN DENNIS M0 citations62
US8563758B2Oct 22, 2013
Method of synthesis of substituted hexitols such as dianhydrogalactitol
BROWN DENNIS M3 citations62
USD352175SNov 8, 1994
Toothbrush
BROWN DENNIS M3 citations62
US10383847B2Aug 20, 2019
Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
BROWN DENNIS M1 citations54
US10138264B2Nov 27, 2018
Recombined molecules and preparation thereof
BROWN DENNIS M0 citations41
US9908259B2Mar 6, 2018
Dual loop control of ceramic precursor extrusion batch
BROWN DENNIS M0 citations37
DELMAR PHARMACEUTICALS INC
6 patentsUS9901563B2Feb 27, 2018
Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
DELMAR PHARMACEUTICALS INC2 citations72
US9814693B2Nov 14, 2017
Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
DELMAR PHARMACEUTICALS INC2 citations70
US11541027B2Jan 3, 2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases
DELMAR PHARMACEUTICALS INC0 citations58
US11446274B2Sep 20, 2022
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies
DELMAR PHARMACEUTICALS INC1 citations58
US11026914B2Jun 8, 2021
Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor
DELMAR PHARMACEUTICALS INC1 citations51
US9630938B2Apr 25, 2017
Method of synthesis of substituted hexitols such as dianhydrogalactitol
DELMAR PHARMACEUTICALS INC0 citations39
MKS INSTR INC
5 patentsUS10304669B1May 28, 2019
Adaptive counter measure control thwarting IMD jamming impairments for RF plasma systems
MKS INSTR INC56 citations96
US10229816B2Mar 12, 2019
Solid-state impedance matching systems including a hybrid tuning network with a switchable coarse tuning network and a varactor fine tuning network
MKS INSTR INC17 citations85
US9041480B2May 26, 2015
Virtual RF sensor
MKS INSTR INC4 citations71
US10536130B2Jan 14, 2020
Balancing RF circuit and control for a cross-coupled SIMO distribution network
MKS INSTR INC0 citations48
US9291649B2Mar 22, 2016
On the enhancements of planar based RF sensor technology
MKS INSTR INC1 citations48
MATRIX PHARMA
4 patentsUS5573781ANov 12, 1996
Methods and compositions for the treatment of a host with a cellular proliferative disease
MATRIX PHARMA104 citations95
US4978332ADec 18, 1990
Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
MATRIX PHARMA75 citations95
USRE35748EMar 17, 1998
Treatments employing drug containing matrices for introduction into cellular lesion areas
MATRIX PHARMA28 citations92
US5874402AFeb 23, 1999
Use of cell membrane permeants in the treatment of cellular proliferative diseases
MATRIX PHARMA17 citations79
AIR PROD & CHEM
3 patentsUS4801574AJan 31, 1989
In-situ activation of CuO/ZnO/Al2 O3 catalysts in the liquid phase
AIR PROD & CHEM20 citations81
US4910227AMar 20, 1990
High volumetric production of methanol in a liquid phase reactor
AIR PROD & CHEM17 citations72
US5858030AJan 12, 1999
Diesel fuel composition comprising dialkoxy alkanes for increased cetane number
AIR PROD & CHEM15 citations70
DEL MAR PHARMACEUTICALS BC LTD
3 patentsUS10201521B2Feb 12, 2019
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma
DEL MAR PHARMACEUTICALS BC LTD1 citations64
US11717505B2Aug 8, 2023
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas
DEL MAR PHARMACEUTICALS BC LTD1 citations57
US11234955B2Feb 1, 2022
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma
DEL MAR PHARMACEUTICALS BC LTD0 citations53
CHEMGENEX PHARMACEUTICALS INC
3 patentsUS7683050B2Mar 23, 2010
Formulations and methods of administration of cephalotaxines, including homoharringtonine
CHEMGENEX PHARMACEUTICALS INC3 citations61
US7642252B2Jan 5, 2010
Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
CHEMGENEX PHARMACEUTICALS INC1 citations51
US7135481B2Nov 14, 2006
Naphthalimide compositions and uses thereof
CHEMGENEX PHARMACEUTICALS INC0 citations51